參考文獻(xiàn)/References:
[1] GBD Spinal Cord Injuries Collaborators.Global,regional,and national burden of spinal cord injury,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J].Lancet Neurol,2023,22(11):1026-1047.
[2] 梅繼林,楊志新,李曉寧.針灸通過(guò)介導(dǎo)炎性反應(yīng)治療脊髓損傷研究進(jìn)展[J].針刺研究,2023,48(7):699-705.
[3] 蘇文碩,安忠誠(chéng),陳晨,等.補(bǔ)陽(yáng)還五湯治療脊髓損傷作用機(jī)制的研究進(jìn)展[J].中醫(yī)正骨,2022,34(8):49-53.
[4] 張劉波.基于Meta分析和網(wǎng)絡(luò)藥理學(xué)探討補(bǔ)陽(yáng)還五湯治療脊髓損傷的療效和機(jī)制[D].北京:北京中醫(yī)藥大學(xué),2021.
[5] 高煜,韓佳慧,葛新.脊髓缺血再灌注損傷后的免疫炎性微環(huán)境[J].中國(guó)組織工程研究,2023,27(8):1300-1305.
[6] 楊云,許光旭.脊髓損傷的神經(jīng)修復(fù)與再生[J].中華物理醫(yī)學(xué)與康復(fù)雜志,2021,4(4):375-379.
[7] LUKACOVA N,KISUCKA A,KISS BIMBOVA K.Glial-neuronal interactions in pathogenesis and treatment of spinal cord injury[J].Int J Mol Sci,2021,22(24):13577.
[8] 王慶鋒,梁學(xué)剛,劉學(xué)起.TLR4/NF-κB信號(hào)通路在脊髓損傷中的作用[J].中國(guó)矯形外科雜志,2021,29(6):531-535.
[9] ASIH P R,PRIKAS E,STEFANOSKA K,et al.Functions of p38 MAP kinases in the central nervous system[J].Front Mol Neurosci,2020,13:570586.
[10] 彭成,劉佩雷,陶鈞,等.急性脊髓損傷后炎癥反應(yīng)、自噬和凋亡相關(guān)因子的變化以及JAK2/STAT3信號(hào)通路研究[J].轉(zhuǎn)化醫(yī)學(xué)雜志,2021,10(2):83-88.
[11] ZHANG C,GUO D,QIAO H,et al.Macrophage extracellular traps exacerbate secondary spinal cord injury by modulating macrophage/microglia polarization via LL37/P2X7R/NF-κB signaling pathway[J].Oxid Med Cell Longev,2022:9197940.
[12] 楊明坤,張旭,黨曉謙,等.巨噬細(xì)胞的極化與脊髓膠質(zhì)瘢痕形成的一般規(guī)律研究[J].實(shí)用骨科雜志,2021,27(6):522-527.
[13] PENG P,YU H,XING C,et al.Exosomes-mediated phenotypic switch of macrophages in the immune microenvironment after spinal cord injury[J].Biomed Pharmacother,2021,144:112311.
[14] MO Y,CHEN K.The role of HMGB1 in spinal cord injury[J].Front Immunol,2023,13:1094925.
[15] 夏宇,丁璐,鄧宇斌.小膠質(zhì)細(xì)胞在脊髓損傷中的作用機(jī)制研究進(jìn)展[J].神經(jīng)損傷與功能重建,2023,18(10):593-596.
[16] LI X,L M,TIAN L,et al.Reactive astrogliosis:Implications in spinal cord injury progression and therapy[J].Oxid Med Cell Longev,2020:9494352.
[17] GAJTKO A,BAKK E,HEGEDUS K,et al.IL-1beta induced cytokine expression by spinal astrocytes can play a role in the maintenance of chronic inflammatory pain[J].Front Physiol,2020,11:543331.
[18] WANG J,CHENG C,LIU Z,et al.Inhibition of A1 astrocytes and activation of A2 astrocytes for the treatment of spinal cord injury[J].Neurochem Res,2023,48(3):767-780.
[19] 劉太聰,張海鴻.A1/A2反應(yīng)性星形膠質(zhì)細(xì)胞活化在脊髓損傷中的作用及其機(jī)制研究進(jìn)展[J].解放軍醫(yī)學(xué)雜志,2023,48(6):723-728.
[20] 張留盼,王宇,夏鋆暉,等.中樞神經(jīng)系統(tǒng)中星形膠質(zhì)細(xì)胞活化機(jī)制的研究進(jìn)展[J].中國(guó)臨床神經(jīng)科學(xué),2021,29(5):569-574.
[21] LEE J Y,PARK C S,SEO K J,et al.IL-6/JAK2/STAT3 axis mediates neuropathic pain byregulating astrocyte and microglia activation after spinal cord injury[J].Exp Neurol,2023,370:114576.
[22] 宋潔菲,周雨昕,張宇,等.炎癥因子及其相關(guān)信號(hào)通路在脊髓損傷調(diào)控機(jī)制中的研究進(jìn)展[J].中國(guó)醫(yī)藥導(dǎo)報(bào),2021,18(32):38-41.
[23] 張曄,李媛,史文心,等.脊髓損傷急性期IL-6的表達(dá)及其動(dòng)態(tài)變化[J].中國(guó)實(shí)用醫(yī)藥,2019,14(32):195-196.
[24] TU Z,LI Y,DAI Y,et al.MiR-140 /BDNF axis regulates normalhuman astrocyte proliferation and LPS-induced IL-6 and TNF-αsecretion[J].Biomed Pharmacother,2017,91:899-905.
[25] ZHENG Z W,CHEN Y H,WU D Y,et al.Development of an accurate and proactive immunomodulatory strategy to improve bone substitute material-mediated osteogenesis and angiogenesis[J].Theranostics,2018,8(19):5482-5500.
[26] 任月喬,徐家淳,吳珺,等.針刺調(diào)控脊髓損傷后免疫炎癥微環(huán)境研究進(jìn)展[J].遼寧中醫(yī)藥大學(xué)學(xué)報(bào),2023,25(7):80-84.
[27] LI J,WANG P,ZHOU T,et al.Neuroprotective effects of interleukin 10 in spinal cord injury[J].Front Mol Neurosci,2023,16:1214294.
[28] YANG L,LI G,YE J,et al.Substance P enhances endogenous neurogenesis to improve functional recovery after spinal cord injury[J].Int J Biochem Cell Biol,2017,89:110-119.
[29] ZHENG Y,WANG N,CHEN Z,et al.Blocking SP/NK1R signaling improves spinal cord hemisection by inhibiting the release of pro-inflammatory cytokines in rabbits[J].J Spinal Cord Med,2022,46(5):848-858.
[30] 謝海洋,王冶,蔣成,等.ICAM-1、HSP70及PAF水平變化與脊髓損傷患者病情及預(yù)后的關(guān)系[J].分子診斷與治療雜志,2021,13(3):491-494.
[31] 齊英娜.補(bǔ)陽(yáng)還五湯對(duì)督脈瘀阻型脊髓損傷內(nèi)質(zhì)網(wǎng)應(yīng)激和血小板活化因子的影響[D].北京:北京中醫(yī)藥大學(xué),2018.
[32] 劉曉敏,王新芹,劉東聲.Ig、CRP、Hcy和RF聯(lián)合檢測(cè)在強(qiáng)直性脊柱炎診斷中的價(jià)值[J].系統(tǒng)醫(yī)學(xué),2022,7(18):78-81.
[33] 杜青蘭.脊髓損傷后TNF-α、IL-6及CRP水平的變化及意義[J].基層醫(yī)學(xué)論壇,2012,16(13):1715-1717.
[34] 李玉婷,雷志強(qiáng),游宇,等.基于TLR4/NF-κB/NLRP3通路探討補(bǔ)陽(yáng)還五湯調(diào)控巨噬細(xì)胞極化的作用機(jī)制[J].中國(guó)實(shí)驗(yàn)方劑學(xué)雜志,2023,29(19):18-25.
[35] 卜獻(xiàn)忠,卜保獻(xiàn),張冠鵬,等.補(bǔ)陽(yáng)還五湯保護(hù)急性脊髓損傷的網(wǎng)絡(luò)藥理學(xué)分析[J].世界科學(xué)技術(shù)-中醫(yī)藥現(xiàn)代化,2024,26(2):375-389.
[36] 盧桃利,霍芳芳,翟中杰,等.槲皮素促進(jìn)小鼠脊髓損傷后巨噬細(xì)胞表型轉(zhuǎn)變及功能恢復(fù)[J].基礎(chǔ)醫(yī)學(xué)與臨床,2018,38(5):686-691.
[37] 鄒禮梁,王奎,滿夏楠,等.補(bǔ)陽(yáng)還五湯對(duì)大鼠脊髓損傷修復(fù)與運(yùn)動(dòng)功能康復(fù)的作用研究[J].云南中醫(yī)學(xué)院學(xué)報(bào),2016,39(4):1-5.
[38] 虞琴,陳洪,王敦林.補(bǔ)陽(yáng)還五湯對(duì)大鼠脊髓損傷后P物質(zhì)表達(dá)的影響[J].時(shí)珍國(guó)醫(yī)國(guó)藥,2009,20(6):1500-1501.
[39] 王紫艷,李磊,劉建勛,等.補(bǔ)陽(yáng)還五湯對(duì)多因素誘導(dǎo)急性血瘀證模型大鼠血小板功能及相關(guān)炎性因子的影響[J].中國(guó)實(shí)驗(yàn)方劑學(xué)雜志,2022,28(21):1-9.
[40] 竇永青,馬濤,李志杰,等.補(bǔ)陽(yáng)還五湯激活PDGF信號(hào)通路促進(jìn)小鼠后肢缺血后動(dòng)脈生成的作用機(jī)制[J].中國(guó)中藥雜志,2024,49(1):216-223.
[41] 徐道志,王茜,楊鐵柱,等.補(bǔ)陽(yáng)還五湯對(duì)頸髓損傷患者紅細(xì)胞分布寬度及急性生理與慢性健康狀況評(píng)分系統(tǒng)Ⅱ的影響[J].中國(guó)中醫(yī)急癥,2020,29(3):498-500.
[42] LIU R,ZOU X,MA L,et al.Meta-analysis of the effect of conventional western medicine therapy supplemented with buyanghuanwu decoction on neurological function and condition improvement of patients with cerebral apoplexy in convalescence[J].Altern Ther Health Med,2023:AT9446.
相似文獻(xiàn)/References:
[1]全仁夫,胡華輝,黃小龍,等.電針秩邊穴和水道穴對(duì)急性脊髓不完全損傷大鼠腦皮質(zhì)代謝物的影響[J].中醫(yī)正骨,2016,28(11):1.
QUAN Renfu,HU Huahui,HUANG Xiaolong,et al.Effect of electroacupuncture at Point BL54(Zhibian)and Point ST28(Shuidao)on cerebral cortex metabolites in rats with acute incomplete spinal cord injuries[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(05):1.
[2]譚明生,齊英娜,姜良海,等.球囊導(dǎo)管構(gòu)建大鼠督脈瘀阻型上頸脊髓損傷模型的研究[J].中醫(yī)正骨,2016,28(12):1.
TAN Mingsheng,QI Yingna,JIANG Lianghai,et al.A governor-vessel-blockade-type upper cervical spinal cord injury rat model created using Foley’s tube[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(05):1.
[3]杜偉斌,陳榮良,俆亦生,等.電針夾脊穴和督脈穴對(duì)急性脊髓損傷家兔后肢神經(jīng)功能的影響及其作用機(jī)制[J].中醫(yī)正骨,2016,28(12):13.
DU Weibin,CHEN Rongliang,XU Yisheng,et al.Effects of electroacupuncture at Point JIAJI(EX-B2)and Point governor vessel on neural function of hindlimbs in rabbits with acute spinal cord injury and the mechanism of action[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(05):13.
[4]齊英娜,王威,吳鑫杰,等.脊髓損傷后微循環(huán)的變化及微循環(huán)障礙的藥物治療進(jìn)展[J].中醫(yī)正骨,2017,29(10):47.
[5]齊英娜,王延雷,吳鑫杰,等.改進(jìn)球囊導(dǎo)管法構(gòu)建大鼠急性壓迫型上頸脊髓損傷模型及模型大鼠傷后早期血液流變學(xué)指標(biāo)觀察[J].中醫(yī)正骨,2017,29(11):26.
QI Yingna,WANG Yanlei,WU Xinjie,et al.Experimental research on acute-compression-type upper cervical spinal cord injury rat models created by using improved Foley's tube method and early observation on post-traumatic hemorheological indexes in rat models[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(05):26.
[6]吳鑫杰,譚明生,移平.NOD樣受體蛋白3炎性小體在創(chuàng)傷性脊髓損傷中的作用[J].中醫(yī)正骨,2019,31(02):31.
[7]范俊馳,宋建東,唐偲,等.電針夾脊穴調(diào)控脊髓損傷后炎癥反應(yīng)的作用機(jī)制研究[J].中醫(yī)正骨,2020,32(05):1.
FAN Junchi,SONG Jiandong,TANG Cai,et al.Study on mechanism of action of electroacupuncture at Point JIAJI(EX-B2)for regulating inflammatory reaction after spinal cord injury[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2020,32(05):1.
[8]王姣姣,周峻,王延雷,等.“椎管減壓,疏通督脈”論治脊髓損傷的學(xué)術(shù)思想探析[J].中醫(yī)正骨,2020,32(10):67.
[9]范佳俊,王君杰,陳烽,等.誘導(dǎo)多能干細(xì)胞移植治療脊髓損傷的研究進(jìn)展[J].中醫(yī)正骨,2021,33(02):54.
[10]李瑋農(nóng),趙繼榮,鄧強(qiáng),等.慢性脊髓損傷動(dòng)物模型的研究進(jìn)展[J].中醫(yī)正骨,2021,33(03):40.
LI Weinong,ZHAO Jirong,DENG Qiang,et al.Advancement of research on animal models of chronic spinal cord injury[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(05):40.